YGION Biomedical is an Austrian biotechnology company, dedicated to make individualized cancer immunotherapy a reality. By applying groundbreaking, innovative technologies, we strive to provide better and more effective treatments to cancer patients.
Our approach encompasses a targeted activation of the patient’s immune system, promising to elicit a fast, strong, and long-lasting specific immune response with an excellent safety profile.
We believe that directing the patient’s immune system specifically against the tumor will provide an opportunity for long-term protection against tumor relapse and metastasis and thus will contribute to an improved success for the treatment of cancer.
Company Details
- Employees
- 12
- Founded
- 2022
- Address
- Vienna, 1030, At
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ygion.bio
- HQ
- Vienna
Ygion Biomedical Questions
Ygion Biomedical's website is https://www.ygion.bio
Ygion Biomedical's LinkedIn profile is https://at.linkedin.com/company/ygion-biomedical
Ygion Biomedical has
12 employees.
View email and phone details for 12
employees at Ygion Biomedical.
Ygion Biomedical's industry is
Biotechnology Research
Ygion Biomedical's top competitors are
Biotech Austria,
G.st Antivirals,
Angios Flexco,
Oncoone,
Sola Diagnostics Gmbh,
Enzyan Biocatalysis Gmbh,
Diamens,
Simvantage,
Brainhero,
Proxygen.
Ygion Biomedical's categories are Biotechnology Research
Ygion Biomedical's founding year is 2022
